111 related articles for article (PubMed ID: 38218560)
1. Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort study.
Vikström S; Syriopoulou E; Andersson TM; Eriksson H
J Am Acad Dermatol; 2024 May; 90(5):963-969. PubMed ID: 38218560
[TBL] [Abstract][Full Text] [Related]
2. The Proportion Cured of Patients with Resected Stage II-III Cutaneous Melanoma in Sweden.
Eriksson H; Utjés D; Olofsson Bagge R; Gillgren P; Isaksson K; Lapins J; Schultz IL; Lyth J; Andersson TM
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070092
[TBL] [Abstract][Full Text] [Related]
3. Reference-Adjusted Loss in Life Expectancy for Population-Based Cancer Patient Survival Comparisons-with an Application to Colon Cancer in Sweden.
Andersson TM; Rutherford MJ; Møller B; Lambert PC; Myklebust TÅ
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1720-1726. PubMed ID: 35700010
[TBL] [Abstract][Full Text] [Related]
4. Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy.
Leontyeva Y; Bower H; Gauffin O; Lambert PC; Andersson TM
BMC Med Res Methodol; 2022 May; 22(1):130. PubMed ID: 35501701
[TBL] [Abstract][Full Text] [Related]
5. Assessing lead time bias due to mammography screening on estimates of loss in life expectancy.
Syriopoulou E; Gasparini A; Humphreys K; Andersson TM
Breast Cancer Res; 2022 Feb; 24(1):15. PubMed ID: 35197123
[TBL] [Abstract][Full Text] [Related]
6. Including uncertainty of the expected mortality rates in the prediction of loss in life expectancy.
Leontyeva Y; Lambe M; Bower H; Lambert PC; Andersson TM
BMC Med Res Methodol; 2023 Dec; 23(1):291. PubMed ID: 38087236
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway.
Winge-Main A; Robsahm TE; Nyakas M; Festervoll G; Torkilseng E; Thybo S; Pati S; Carroll R
Future Oncol; 2023 Jan; 19(3):205-215. PubMed ID: 36974621
[TBL] [Abstract][Full Text] [Related]
8. A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden.
Isaksson K; Katsarelias D; Mikiver R; Carneiro A; Ny L; Olofsson Bagge R
Ann Surg Oncol; 2019 Sep; 26(9):2839-2845. PubMed ID: 31111349
[TBL] [Abstract][Full Text] [Related]
9. Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer.
Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Landefeld CS; Chren MM
JAMA Intern Med; 2013 Jun; 173(11):1006-12. PubMed ID: 23699934
[TBL] [Abstract][Full Text] [Related]
10. The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study.
Eriksson H; Lyth J; Andersson TM
Int J Cancer; 2016 Jun; 138(12):2829-36. PubMed ID: 26815934
[TBL] [Abstract][Full Text] [Related]
11. Loss in Life Expectancy After Surgical Aortic Valve Replacement: SWEDEHEART Study.
Glaser N; Persson M; Jackson V; Holzmann MJ; Franco-Cereceda A; Sartipy U
J Am Coll Cardiol; 2019 Jul; 74(1):26-33. PubMed ID: 31272548
[TBL] [Abstract][Full Text] [Related]
12. Life expectancy and expected years of life lost to oral cancer in Taiwan: a nation-wide analysis of 22,024 cases followed for 10 years.
Huang CC; Ou CY; Lee WT; Hsiao JR; Tsai ST; Wang JD
Oral Oncol; 2015 Apr; 51(4):349-54. PubMed ID: 25604257
[TBL] [Abstract][Full Text] [Related]
13. A simplified estimation of loss of life expectancy (LLE) using rectangular approximation method.
Watanabe N; Mizutani S; Takatsuki H
Environ Sci; 2007; 14(1):9-14. PubMed ID: 17450116
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H
Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457
[TBL] [Abstract][Full Text] [Related]
15. Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma.
Kanaki T; Stang A; Gutzmer R; Zimmer L; Chorti E; Sucker A; Ugurel S; Hadaschik E; Gräger NS; Satzger I; Schadendorf D; Livingstone E
Eur J Cancer; 2019 Sep; 119():18-29. PubMed ID: 31401470
[TBL] [Abstract][Full Text] [Related]
16. Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort.
Hieken TJ; Glasgow AE; Enninga EAL; Kottschade LA; Dronca RS; Markovic SN; Block MS; Habermann EB
J Womens Health (Larchmt); 2020 Sep; 29(9):1160-1167. PubMed ID: 32105561
[No Abstract] [Full Text] [Related]
17. Loss of life expectancy from air pollution compared to other risk factors: a worldwide perspective.
Lelieveld J; Pozzer A; Pöschl U; Fnais M; Haines A; Münzel T
Cardiovasc Res; 2020 Sep; 116(11):1910-1917. PubMed ID: 32123898
[TBL] [Abstract][Full Text] [Related]
18. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.
Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murata N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
J Dermatol Sci; 2019 May; 94(2):284-289. PubMed ID: 31023613
[TBL] [Abstract][Full Text] [Related]
19. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
